Patents by Inventor Matthew Sander

Matthew Sander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS FOR EGG ORAL IMMUNOTHERAPY, METHODS OF MANUFACTURE, AND TREATMENTS FOR EGG ALLERGY
    Publication number: 20220046948
    Abstract: Described herein are egg white protein formulations, dosage containers containing the egg white protein formulations, methods of making the egg white protein formulations and dosage containers, and methods of controlling the quality of the egg white protein formulations, materials for manufacturing the egg white protein formulation (such as dried egg white protein powder), and the dosage containers. Further described herein are oral immunotherapy methods for treating an egg allergy. The method includes orally administering to the patient doses of a pharmaceutical composition comprising egg white protein according to an oral immunotherapy schedule. Also described herein are methods of adjusting a dosage of the pharmaceutical composition during oral immunotherapy if the patient experiences an adverse event related to the administration of a dose or a concurrent factor associated with increased sensitivity to an allergen that is not related to the administration of the dose.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 17, 2022
    Inventors: Reyna J. SIMON, Nicholas William BIRRINGER, Matthew SANDER, Christina CAPULE, Kari Rose BROWN, Stephen G. DILLY, Daniel ADELMAN
  • Liquid insulin formulations and methods relating thereto
    Patent number: 11096990
    Abstract: Liquid formulations of insulin that contain physically and chemically stable insulin but do not contain preservatives or stabilizers are provided. The formulations also lack surfactants. The formulations are useful for various modes of delivery including pulmonary delivery.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: August 24, 2021
    Assignee: AERAMI THERAPEUTICS, INC.
    Inventors: Blaine Bueche, Mei-Chang Kuo, John Patton, Matthew Sander
  • Liquid insulin formulations and methods relating thereto
    Patent number: 10842951
    Abstract: Liquid formulations of insulin that contain physically and chemically stable insulin but do not contain preservatives or stabilizers are provided. The formulations also lack surfactants. The formulations are useful for various modes of delivery including pulmonary delivery.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: November 24, 2020
    Assignee: Aerami Therapeutics, Inc.
    Inventors: Blaine Bueche, Mei-Chang Kuo, John Patton, Matthew Sander
  • INSULIN FORMULATIONS FOR RECONSTITUTION INTO HIGH CONCENTRATION LIQUID SOLUTIONS
    Publication number: 20190343768
    Abstract: A dry powder insulin formulation for reconstitution including insulin, a buffering agent, and a salt. The dry powder insulin formulation includes between about 70 and 95% w/w of insulin, between about 5 and 30% w/w of the buffering agent, and less than about 1% w/w of the salt. The dry powder insulin formulation has less than about 5% water content.
    Type: Application
    Filed: May 14, 2019
    Publication date: November 14, 2019
    Inventors: Blaine Bueche, Matthew Sander, Mei-chang Kuo
  • LIQUID INSULIN FORMULATIONS AND METHODS RELATING THERETO
    Publication number: 20190160153
    Abstract: Liquid formulations of insulin that contain physically and chemically stable insulin but do not contain preservatives or stabilizers are provided. The formulations also lack surfactants. The formulations are useful for various modes of delivery including pulmonary delivery.
    Type: Application
    Filed: October 23, 2018
    Publication date: May 30, 2019
    Applicant: Dance BioPharm, Inc.
    Inventors: Blaine Bueche, Mei-Chang Kuo, John Patton, Matthew Sander
  • LIQUID INSULIN FORMULATIONS AND METHODS RELATING THERETO
    Publication number: 20190054259
    Abstract: Liquid formulations of insulin that contain physically and chemically stable insulin but do not contain preservatives or stabilizers are provided. The formulations also lack surfactants. The formulations are useful for various modes of delivery including pulmonary delivery.
    Type: Application
    Filed: October 23, 2018
    Publication date: February 21, 2019
    Applicant: Dance BioPharm, Inc.
    Inventors: Blaine Bueche, Mei-Chang Kuo, John Patton, Matthew Sander
  • LIQUID INSULIN FORMULATIONS AND METHODS RELATING THERETO
    Publication number: 20160243199
    Abstract: Liquid formulations of insulin that contain physically and chemically stable insulin but do not contain preservatives or stabilizers are provided. The formulations also lack surfactants. The formulations are useful for various modes of delivery including pulmonary delivery.
    Type: Application
    Filed: December 21, 2015
    Publication date: August 25, 2016
    Applicant: Dance BioPharm, Inc.
    Inventors: Blaine Bueche, Mei-Chang Kuo, John Patton, Matthew Sander